Sunshine Biopharma (SBFM) Earnings (2010 - 2026)
Sunshine Biopharma (SBFM) earnings from Mar 31, 2010 to Mar 31, 2026. The TTM Sunshine Biopharma (SBFM) earnings is -$6.03M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Sunshine Biopharma (SBFM) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +110.10% |
| 3 Years TTM | -39.49% |
| 5 Years TTM | -5.02% |
| 10 Years TTM | +13.70% |
Annual Earnings change of Sunshine Biopharma (SBFM)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$1.24M | -79.26% |
| 2025 | -$5.98M | +16.57% |
| 2024 | -$5.13M | +13.75% |
| 2023 | -$4.51M | -83.13% |
| 2022 | -$27M | +114.95% |
| 2021 | -$12M | +347.48% |
| 2020 | -$2.78M | +67.47% |
| 2019 | -$1.66M | -23.15% |
| 2018 | -$2.16M | +107.69% |
| 2017 | -$1.04M | -70.29% |
| 2016 | -$3.50M | +112.12% |
| 2015 | -$1.65M | -14.51% |
| 2014 | -$1.93M | -22.49% |
| 2013 | -$2.49M | +250.70% |
| 2012 | -$710K | +26.79% |
| 2011 | -$560K | +3.70% |
| 2010 | -$540K | -1.82% |
| 2009 | -$550K | N/A |
Comparison Sunshine Biopharma (SBFM) five years earnings CAGR with competitors
Sunshine Biopharma (SBFM) five years earnings CAGR is 23.97%.
| Ticker | Name | five years Earnings CAGR | Upside |
|---|---|---|---|
| AMPH | Amphastar Pharmaceuticals Inc | 99.69% | +315.96% |
| INCR | INC Research Holdings Inc | 64.08% | +167.39% |
| TLRY | Tilray Brands Inc | 57.78% | +141.06% |
| PRGO | Perrigo Company plc | 51.08% | +113.14% |
| CPIX | Cumberland Pharmaceuticals Inc | 28.38% | +18.42% |
| UTHR | United Therapeutics Corp | 26.00% | +8.48% |
| RDY | Dr. Reddy`s Laboratories Ltd | 21.66% | -9.63% |
| AYTU | Aytu BioPharma Inc | 21.24% | -11.36% |
| PAHC | Phibro Animal Health Corp - Class A | 17.29% | -27.87% |
| BCRX | Biocryst Pharmaceuticals Inc | 16.93% | -29.35% |
| SNOA | Sonoma Pharmaceuticals Inc | 11.83% | -50.65% |
| NBIX | Neurocrine Biosciences Inc | 10.71% | -55.31% |
| CRDL | Cardiol Therapeutics Inc - Class A | 10.44% | -56.46% |
| ZTS | Zoetis Inc - Class A | 8.54% | -64.38% |
| KMDA | Kamada Ltd | 6.87% | -71.33% |
| AQST | Aquestive Therapeutics Inc | 5.03% | -79.03% |
| PRFX | PRF Technologies Ltd | 4.38% | -81.72% |
| SXTC | China SXT Pharmaceuticals Inc | 3.75% | -84.35% |
| CPHI | China Pharma Holdings Inc | 3.58% | -85.06% |
| BHC | Bausch Health Companies Inc | 3.48% | -85.47% |
| PBH | Prestige Consumer Healthcare Inc | 2.93% | -87.76% |